HomeATRA • NASDAQ
add
Atara Biotherapeutics Inc
Previous close
$15.69
Day range
$15.36 - $17.25
Year range
$5.01 - $18.70
Market cap
121.35M USD
Avg Volume
65.42K
P/E ratio
7.67
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 3.45M | -91.41% |
Operating expense | 3.98M | -61.86% |
Net income | -4.30M | 80.36% |
Net profit margin | -124.62 | -128.62% |
Earnings per share | -0.32 | 89.08% |
EBITDA | -3.19M | 84.08% |
Effective tax rate | -0.65% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 13.71M | -79.59% |
Total assets | 30.17M | -78.86% |
Total liabilities | 66.80M | -71.36% |
Total equity | -36.63M | — |
Shares outstanding | 7.21M | — |
Price to book | -3.09 | — |
Return on assets | -26.44% | — |
Return on capital | 47.87% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -4.30M | 80.36% |
Cash from operations | -9.79M | -145.35% |
Cash from investing | -2.42M | 85.47% |
Cash from financing | 1.05M | -97.07% |
Net change in cash | -11.16M | -173.72% |
Free cash flow | -1.01M | -135.89% |
About
Founded
2012
Headquarters
Website
Employees
38
